These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12986697)

  • 1. Proguanil-resistant Plasmodium falciparum in Assam.
    GILROY AB
    Ann Trop Med Parasitol; 1952 Sep; 46(2):121-6. PubMed ID: 12986697
    [No Abstract]   [Full Text] [Related]  

  • 2. Proguanil for malaria prophylaxis.
    Colbourne MJ; Draper CC
    Lancet; 1983 May; 1(8335):1228. PubMed ID: 6134033
    [No Abstract]   [Full Text] [Related]  

  • 3. Why not proguanil in malaria prophylaxis?
    Olsen VV
    Lancet; 1983 Mar; 1(8325):649. PubMed ID: 6131328
    [No Abstract]   [Full Text] [Related]  

  • 4. From the Centers for Disease Control and Prevention. Malaria deaths following inappropriate malaria chemoprophylaxis--United States, 2001.
    JAMA; 2001 Aug; 286(7):783-4. PubMed ID: 11519496
    [No Abstract]   [Full Text] [Related]  

  • 5. Experiment to determine if a proguanil-resistant strain of P. falciparum would respond to large doses of pyrimethamine.
    JONES SA
    Br Med J; 1953 May; 1(4817):977. PubMed ID: 13032585
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant malaria.
    Lancet; 1969 Jun; 1(7608):1245. PubMed ID: 4182418
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term chloroquine-proguanil malaria prophylaxis in a nonimmune pediatric population.
    Gozal D; Fadat G; Hengy C
    J Pediatr; 1991 Jan; 118(1):142-5. PubMed ID: 1986083
    [No Abstract]   [Full Text] [Related]  

  • 10. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proguanil-sulphonamide for malaria prophylaxis.
    Karwacki JJ; Shanks GD; Limsomwong N; Singharaj P
    Trans R Soc Trop Med Hyg; 1990; 84(1):55-7. PubMed ID: 2189248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiments with antimalarial drugs in man. IV. An experiment to investigate the prophylactic value of proguanil against a strain of Plasmodium falciparum known to be resistant to therapeutic treatment.
    DAVEY DG; ROBERTSON GI
    Trans R Soc Trop Med Hyg; 1957 Sep; 51(5):463-6. PubMed ID: 13468008
    [No Abstract]   [Full Text] [Related]  

  • 13. Experiments with antimalarial drugs in man. I. The protective effect of proguanil (paludrine) against an East African strain of Plasmodium falciparum transmitted by Anopheles gambiae.
    THOMAS AT; ROBERTSON GI; DAVEY DG
    Trans R Soc Trop Med Hyg; 1953 Jul; 47(4):338-45. PubMed ID: 13090297
    [No Abstract]   [Full Text] [Related]  

  • 14. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New options for the prevention and treatment of malaria: focus on the role of atovaquone and proguanil hydrochloride.
    Shanks GD
    J Travel Med; 1999 May; 6 Suppl 1():S1. PubMed ID: 23573544
    [No Abstract]   [Full Text] [Related]  

  • 16. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract]   [Full Text] [Related]  

  • 17. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA.
    LUNN JS; CHIN W; CONTACOS PG; COATNEY GR
    Am J Trop Med Hyg; 1964 Nov; 13():783-5. PubMed ID: 14222428
    [No Abstract]   [Full Text] [Related]  

  • 19. Mass proguanil prophylaxis.
    Saarinen M; Thoren E; Iyambo N; Carlstedt A; Shinyafa L; Fernanda M; Paajanen H; Paajanen K; Indongo I; Rombo L
    Lancet; 1987 Apr; 1(8539):985-6. PubMed ID: 2882383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.